Log In
Print
BCIQ
Print
Print this Print this
 

BVT.115959

  Manage Alerts
Collapse Summary General Information
Company Swedish Orphan Biovitrum AB
DescriptionAdenosine A2A receptor agonist
Molecular Target Adenosine A2A receptor (ADORA2A)
Mechanism of ActionAdenosine A2A receptor agonist
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase II
Standard IndicationPain
Indication DetailsTreat diabetic neuropathic pain (DNP); Treat neuropathic pain
Regulatory Designation

Partner

CBT Development Ltd.; Ergomed Clinical Research Ltd.


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today